These are the stocks posting the largest moves before the bell.Market Insiderread more
U.S. stock futures pointed to a higher open on Monday as Treasury yields rebounded to quell fears of a possible recession.US Marketsread more
The Business Roundtable, a group of CEOs of nearly 200 major U.S. corporations, gave a new definition of the "purpose of a corporation."Marketsread more
Trump said he doesn't see a recession after the bond market spooked investors and the Dow suffered its worst day of the year last week.Marketsread more
Bianco Research's James Bianco suggests Wall Street is desperately looking for a signal that a 50 basis point cut is coming next month.Trading Nationread more
Amid the headlines of stores closures and retail bankruptcies, it can be tough to accept that the U.S. consumer is doing just fine.Retailread more
U.S. Commerce Secretary Wilbur Ross said the U.S. will extend a reprieve given to Huawei that permits the Chinese firm to buy supplies from U.S. companies.Politicsread more
Here are the biggest calls on Wall Street on MondayInvestingread more
Dow to jump; Trump defends economy; Huawei hopes for US reprieve; Trump and Apple's Tim Cook meet; president ties Hong Kong protests to China trade disputeMarketsread more
We tested the best way to cut the airport commute time for New Yorkers. The most expensive of the four options we reviewed, Uber Copter, was only 14 minutes faster than mass...Transportationread more
The U.K. prime minister prepares to meet his German and French counterparts this week.Europe Politicsread more
The London-based company said Friday that it was now worth $2 billion following the fundraising, which also saw German reinsurer Munich Re's ERGO Fund and an undisclosed U.S. health insurer — which a Sky News report identified as Centene — invest.
Babylon said that $450 million of capital has already been committed, and includes an option for one investor to pump another $50 million at a later date. The remainder of the round will be closed shortly, the firm added.
The start-up is known for its work with the U.K.'s National Health Service. The company built a platform for the NHS that lets patients book consultations with a doctor over video call using their smartphone. It also has contracts with Samsung, Prudential and Bupa.
It attracted criticism from health professionals last year over a claim that its artificial intelligence software could diagnose medical conditions as accurately as a doctor. The firm's chatbot, which patients interact with, scored a higher-than-average test score on a practice exam compiled for physicians.
"This investment will allow us to maximise the number of lives we touch across the world," Dr Ali Parsa, founder and CEO of Babylon, said in a statement. "We have a long way to go and a lot still to deliver."
He added: "We have seen significant demand from partners across the US and Asia. While the burden of healthcare is global, the solutions have to be localised to meet the specific needs and culture of each country."
The firm is one of many tech businesses looking to disrupt the health industry, with behemoths from Apple to Amazon looking to tap into the trend. U.S. consultancy Deloitte forecasts that spending on health care will grow to about $10 trillion globally by 2022.
The fresh cash injection gives Babylon the coveted status of being a "unicorn," meaning a private company that's worth $1 billion or more. It said the capital raised will be used to fund extensive product innovation around chronic conditions and an expansion into the U.S. and Asia.